Skip to main content

Table 2 Biomarkers, LV volumes, LV mass, ischemia and scar burden in the three study groups.

From: Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction

 

A

NSTEMI (n = 25)

B

Non-Q STEMI (n = 25)

C

Q-STEMI (n = 25)

A vs B

p*

A vs C

p*

B vs C

p*

Troponin I (mg/ml)

5.9 (± 15.7)

29.6 (± 30.3)

69.9 (± 60.4)

>0.05

<0.001

<0.05

Peak CK (IU)

396 (± 421.8)

1289 (± 818)

2253 (± 1524)

<0.05

<0.001

<0.01

Anterior MI

-

8

12

   

Inferior/lateral MI

-

17

13

   

LVEDV (ml)

172.5 (± 51.3)

175.0 (± 40.8)

186.9 (± 29.3)

>0.05

>0.05

>0.05

LVESV (ml)

80.0 (± 44.8)

94.9 (± 32.5)

107.1 (± 25.1)

>0.05

<0.05

>0.05

LV EF (%)

55.5 (± 9.5)

46.6 (± 7.3)

43.1 (± 7.8)

<0.001

<0.001

>0.05

LV mass (g)

133.1 (± 36.3)

115.3 (± 26.7)

131.7 (± 24.9)

>0.05

>0.05

>0.05

Scar %

3.8 (± 5.3)

15.2 (± 8.4)

24.1 (± 12.6)

<0.001

<0.001

<0.01

Ischemia %

19.9 (± 20.1)

14.7 (± 12.6)

6.9 (± 11.4)

>0.05

<0.01

>0.05

  1. Data presented as mean ± SD.
  2. * All statistical comparisons by ANOVA post hoc tests. CK = creatine kinase; LV = left ventricle; EDV = end diastolic volume; ESV = end systolic volume; EF = ejection fraction.